William Meury Syndax Pharmaceuticals Inc (SNDX) insider trading activity

SNDX Quotes by TradingView

William Meury is of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 65,000 shares of SNDX, which is worth approximately $1.21 Million. The most recent transaction as insider was on Feb 07, 2024, when has been sold 17,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65K
0% 3M change
35.42% 12M change
Total Value Held $1.21 Million

William Meury Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 07 2024
BUY
Grant, award, or other acquisition
-
17,000 Added 20.73%
65,000 Common Stock
Aug 02 2023
SELL
Open market or private sale
$1,698,180 $20.46 p/Share
83,000 Reduced 63.36%
48,000 Common Stock
Aug 02 2023
BUY
Exercise of conversion of derivative security
$676,450 $8.15 p/Share
83,000 Added 53.55%
72,000 Common Stock
Feb 02 2023
BUY
Grant, award, or other acquisition
-
16,000 Added 25.0%
48,000 Common Stock
Feb 02 2022
BUY
Grant, award, or other acquisition
-
16,000 Added 33.33%
32,000 Common Stock
Feb 03 2021
BUY
Grant, award, or other acquisition
-
16,000 Added 50.0%
16,000 Common Stock

Also insider at

KRTX
Karuna Therapeutics, Inc. Healthcare
President and CEO
WM

William Meury

Waltham, MA

Track Institutional and Insider Activities on SNDX

Follow Syndax Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNDX shares.

Notify only if

Insider Trading

Get notified when an Syndax Pharmaceuticals Inc insider buys or sells SNDX shares.

Notify only if

News

Receive news related to Syndax Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SNDX